Status:
WITHDRAWN
Barriers to Referring Adolescent Women for Etonogestrel Implant.
Lead Sponsor:
Nemours Children's Clinic
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Contraceptive Usage
Eligibility:
All Genders
22+ years
Phase:
NA
Brief Summary
This study seeks to understand how much pediatric providers in Central Florida know about the etonogestrel contraceptive implant. The investigators also seek to understand the barriers that may preven...
Detailed Description
This study is comprised of two phases. During the first phase 500 medical providers who provide care to adolescents will be recruited to complete a 30 question anonymous survey that evaluates their at...
Eligibility Criteria
Inclusion
- A primary care provider that cares for children under the age of 18. This includes physician's assistants, advanced nurse practitioners, residents or fellows, and physicians in pediatrics, internal medicine, and family medicine.
- Must currently be practicing in Central Florida.
- Be able to speak and write in English
- For phase two of the study an additional requirement is that you must have a medical license to practice independently in the state of Florida.
Exclusion
- Not a primary care provider who cares for children.
- A pediatric provider who only provides specialty care
- Not able to speak or write in English
- For phase two of study does not have a medical license to practice independenly in the State of Florida.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04882137
Start Date
September 1 2023
End Date
June 30 2024
Last Update
September 21 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.